Navigation Links
CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
Date:10/4/2007

LAGUNA HILLS, Calif., Oct. 4 /PRNewswire-FirstCall/-- CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech and pharmaceutical research markets and to academic institutions, today announced a corporate update.

LifeStem(TM), Inc., a CalbaTech wholly-owned subsidiary that has developed a unique process to harvest adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client for medical purposes, will be in Atlanta, Georgia this week to train employees of a medspa that will begin selling the Stem Cell Microbank(TM) Service in its Atlanta location. Pre-marketing of the service in the "Atlanta Life" magazine has, according to the owner of the spa, resulted in significant interest by potential clients. LifeStem(TM) will be training the staff in both selling and harvesting techniques.

TherapyStem, Inc., a wholly-owned subsidiary of CalbaTech, signed an MOU with Australian-based Benitec Limited, in which TherapyStem will develop a business providing stem cell storage services for U.S. HIV patients who may use the blood-based stem cells in a possible therapy. Benitec has collaborated with City of Hope, Duarte, California, a biomedical research and treatment center, in the development of a possible HIV therapeutic. This investigational HIV therapeutic creates the possibility that re-engineered blood-based stem cells may be able to take the place of anti-retroviral medication. TherapyStem, Inc. has filed for patent protection for its process to harvest stem cells from HIV infected individuals to be cryopreserved for future transplantation.

MyStem, Inc., a developing wholly-owned subsidiary of CalbaTech, is working to build a platform in which it will sell Li
'/>"/>

SOURCE CalbaTech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Stabilizing RNA in Fresh and Frozen Tissues for RNA Isolation
2. Genomic DNA Preparation from RNAlater Preserved Tissues
3. Preparation of PCR Quality Template DNA from a Wide Range of Tissues Using InstaGene Matrix
4. Using the VersaFluor Fluorometer to Quantitate GUS Expression in Plant Tissues Bombarded With the Biolistic PDS-1000/He System
5. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
6. Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data
7. Evaluation of RNA isolated from human tissues: quality control for surgical and postmortem samples
8. Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA)
9. Inline intellectual property raises legal issues
10. SC Johnson issues trademark warning over web offer
11. Company issues warning on outsourced software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... a new explanation for differences in the severity of mental ... gene, the more serious the handicap. The genetic defect is ... is the amount of copies of the GDI1 gene that ... American Journal of Human Genetics , and are the result ... VIB, a life sciences research institute in Flanders, Belgium at ...
(Date:12/11/2009)... Ambit Biosciences Corporation announced today the enrollment ... Anderson Cancer Center of the first patient in the ... E fficacy) Phase 2 pivotal trial in patients ... AC220 is a novel, orally available, potent and highly ... FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ACE study ...
(Date:12/11/2009)... -- Marrone Bio Innovations (MBI) today announces 2 ... Chris Hildreth joined MBI as Senior Vice President ... all commercial aspects of the company, including sales, ... (Ray) Lam joined MBI as Vice President of ... in scaling its broad pipeline of products to ...
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... NanoLogix, Inc. (OTC: NNLX) a biotechnology company, announces director ... and Jeff Long to the Board of Directors. Daniel ... Michigan State University College of Law, where he ... securities, and commercial law. In addition to his academic ...
... NEOG ) has received approval from the FDA ... quick and easy BetaStar(R)US test,for dairy antibiotics in milk. ... States to use Neogen,s new test to comply with ... dairy antibiotics. , Neogen,s newly ...
... Inc. (NYSE Alternext US : SYI) ... double-blind, placebo-controlled, randomized trial of the Company,s compound alagebrium. The ... exercise tolerance in patients with chronic systolic heart failure. In ... B eginning a R andomized E valuation of ...
Other Biology Technology:NanoLogix Inc. Appoints Two New Directors and Provides Operations Update 2NanoLogix Inc. Appoints Two New Directors and Provides Operations Update 3Neogen's BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 4
(Date:12/10/2009)... DNA that interrupt genes could be far more important ... to a recent Science report by Indiana University Bloomington ... of the model organism Daphnia pulex (water ... a single lineage by "introns," as the interrupting sequences ... the genome far more frequently than current models predict. ...
(Date:12/10/2009)... KNOXVILLE, TNNew varieties of plants marketed as "disease-resistant" ... Available through local garden centers and catalogues, these ... amateur gardeners the promise of lower maintenance or ... does this trend toward the increased use of ... landscape and lawn care professionals, whose incomes often ...
(Date:12/10/2009)... K. SenGupta, Ph.D., a professor of civil, environmental ... Pa., has been chosen to receive a 2009 ... the American Chemical Society, is given to individuals ... improve public health through their work in the ... a $30,000 grant to support his continuing research ...
Breaking Biology News(10 mins):Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4Experts: Disease-resistant plants enhance profits, client satisfaction 2August is National Childrens Vision and Learning Month 49366 1August is National Childrens Vision and Learning Month 49366 2August is National Childrens Vision and Learning Month 49366 3Bill Hayes Promoted to President of Vendormate 49362 1Bill Hayes Promoted to President of Vendormate 49362 2Animes fan girls 49360 1Animes fan girls 49360 2
... study to date of 130 North American tree species ... their ranges northward by hundreds of kilometers and shrink ... Daniel W. McKenney of the Canadian Forest Service and ... BioScience. , McKenneys study is based on an extensive ...
... an exercise-related gene in the brain works as a ... a new anti-depressant drug target, according to a Yale ... VGF exercise-related gene and target for drug development could ... already present in the brain, said Ronald Duman, professor ...
... -- The compound sulforaphane whose natural precursors ... other cruciferous vegetables has been hailed for its ... new skills in treating a genetic skin blistering ... and colleagues at the Johns Hopkins University School ...
Other Biology News:Climate change predicted to drive trees northward 2Newly-identified exercise gene could help with depression 2Natural compound in broccoli could treat devastating genetic skin disorder 2
... Endogenous potent vasoconstrictor peptide. Displays selectivity for ... tonus. ET-1, ET-2, and ET-3 are the ... and ET-3 are similar to ET-1, but ... respectively. All three isopeptides produce strong in ...
Human sVCAM-1/CD106 ELI-PAIR Kit...
HNF-1 Purified Anti-Mouse, Anti-Rat, Anti-Rabbit, Anti-Human clone 2, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
GLP-1 (HYB 147-12)...
Biology Products: